Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Beta-adrenergic receptor and Alpha-1 adrenergic receptor are subclasses of adrenergic receptors—G protein-coupled receptors that mediate the physiological effects of the catecholamines norepinephrine and epinephrine. Beta-1 adrenergic receptors are primarily expressed in the heart and kidneys and are key regulators of heart rate, myocardial contractility, and renin release. Alpha-1 adrenergic receptors, found mostly on smooth muscle of blood vessels and organs, drive vasoconstriction and blood pressure regulation, and also participate in other smooth muscle contractions throughout the body. Both receptor families are major drug targets in cardiovascular, neurological, and certain metabolic diseases, with well-established agonists and antagonists used therapeutically.
β1-AR: Agonists: Increase heart rate, contractility, conduction velocity via Gs and cAMP signaling. Antagonists: Decrease heart rate, blood pressure; block catecholamine effects (used in hypertension, arrhythmia, etc.). α1-AR: Agonists: Vasoconstriction by activating Gq, IP₃/DAG pathway, increasing intracellular calcium. Antagonists: Vasodilation, reduced blood pressure; relax smooth muscle in bladder/prostate.
12 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Beta-adrenoceptor and Alpha1-adrenoceptor (β1-AR and α1-AR).